Search
Filter Results
Displaying 231–240 of 257 for “adeno-associated virus”
-
Dec 19, 2016
A Change in Identity Might Someday Save Vision
By changing the identity of cells in the retina–namely rods–researchers may someday be able to slow or halt vision loss for those with retinitis pigmentosa (RP) and other related conditions.
-
Oct 6, 2016
Embrace Your Exceptions: A Mantra for Understanding Retinal-Disease Inheritance
The complex and elusive nature of these conditions can also extend to the way they are passed down in families, making diagnosis and prognosis quite challenging.
-
May 4, 2016
ARVO 2016: Emerging Drug Targets Toxic Build-Up in Stargardt Disease
In August 2015, the biotech company Alkeus launched a multi-center TEASE Phase II clinical trial for the drug ALK-001.
-
Apr 28, 2016
ARVO 2016: Choroideremia Gene Therapy in Clinical Trial Continues to Perform Well
Five of six patients in NightStaRx’s choroideremia gene-therapy trial continue to benefit from the treatment.
-
Oct 8, 2015
A Leap Forward: Spark Therapeutics Seeks FDA Approval for its Vision-Restoring Gene Therapy
-
Oct 10, 2014
Genetics 101: How Some Retinal Diseases are Inherited
To understand heredity, you have to know a little about genetics. Below is a review of the three major genetic-disease inheritance patterns.
-
Aug 7, 2014
Inspired by Progress in Usher Syndrome Research
Mark Pennesi, M.D., Ph.D., a Foundation-funded clinical researcher at the Casey Eye Institute, discusses the first human study of gene therapy for Usher syndrome type 1B.
-
May 8, 2014
ARVO 2014: European Collaboration Developing Cross-Cutting, Vision-Saving Therapies
Simply put, they’re creating therapies that can save vision in as many people as possible, independent of the genetic cause of disease.
-
Oct 30, 2013
Urine Test Helps Diagnose RP Caused by DHDDS Mutations
While it isn’t a substitute for a diagnosis through genetic testing, the urine test can verify that a given DHDDS mutation is, in fact, causing RP.
-
Aug 22, 2013
The Invaluable Role of the Retinal Specialist
Until therapies become readily available, it’s important for patients and families to establish an ongoing relationship with a retinal specialist familiar with retinal degenerations.